drugset / Trial / NCT07076290
A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD
NaSingle-groupOpen-labelTreatment
Summary
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate chronic obstructive pulmonary disease (COPD)
Timeline
- Start
- 2026-09-01
- Primary completion
- 2028-04-30
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | R-3750 | Other / unclassified | — | Oral |